Antihypertensive therapy

Details for Australian Patent Application No. 2007217100 (hide)

Owner Gilead Colorado, Inc.

Inventors Gerber, Michael J.; Roden, Robert L.; Gorczynski, Richard J.

Agent EF WELLINGTON & CO

Pub. Number AU-A-2007217100

PCT Pub. Number WO2007/098387

Priority 60/774,738 17.02.06 US; 60/774,739 17.02.06 US; 60/774,884 17.02.06 US; 60/774,560 17.02.06 US

Filing date 16 February 2007

Wipo publication date 30 August 2007

International Classifications

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/098387 Priority application(s): WO2007/098387

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217101-Oxa-steroids derivatives as selective progesterone receptor modulators

2007217099-Pyrazolylquinazolinones as potassium channel openers